• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CAG RNAs 通过沉默多聚谷氨酰胺变性中的表达诱导 DNA 损伤和细胞凋亡。

CAG RNAs induce DNA damage and apoptosis by silencing expression in polyglutamine degeneration.

机构信息

Laboratory of Drosophila Research, The Chinese University of Hong Kong, Hong Kong, China.

School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

Proc Natl Acad Sci U S A. 2021 May 11;118(19). doi: 10.1073/pnas.2022940118.

DOI:10.1073/pnas.2022940118
PMID:33947817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8126783/
Abstract

DNA damage plays a central role in the cellular pathogenesis of polyglutamine (polyQ) diseases, including Huntington's disease (HD). In this study, we showed that the expression of untranslatable expanded CAG RNA per se induced the cellular DNA damage response pathway. By means of RNA sequencing (RNA-seq), we found that expression of the () gene was down-regulated in mutant CAG RNA-expressing cells. The loss of NUDT16 function results in a misincorporation of damaging nucleotides into DNAs and leads to DNA damage. We showed that small CAG (sCAG) RNAs, species generated from expanded CAG transcripts, hybridize with CUG-containing mRNA and form a CAG-CUG RNA heteroduplex, resulting in gene silencing of and leading to the DNA damage and cellular apoptosis. These results were further validated using expanded CAG RNA-expressing mouse primary neurons and in vivo R6/2 HD transgenic mice. Moreover, we identified a bisamidinium compound, DB213, that interacts specifically with the major groove of the CAG RNA homoduplex and disfavors the CAG-CUG heteroduplex formation. This action subsequently mitigated RNA-induced silencing complex (RISC)-dependent silencing in both in vitro cell and in vivo mouse disease models. After DB213 treatment, DNA damage, apoptosis, and locomotor defects were rescued in HD mice. This work establishes NUDT16 deficiency by CAG repeat RNAs as a pathogenic mechanism of polyQ diseases and as a potential therapeutic direction for HD and other polyQ diseases.

摘要

DNA 损伤在包括亨廷顿病(HD)在内的多聚谷氨酰胺(polyQ)疾病的细胞发病机制中起着核心作用。在这项研究中,我们表明,未翻译的扩增 CAG RNA 的表达本身就会诱导细胞 DNA 损伤反应途径。通过 RNA 测序(RNA-seq),我们发现在表达突变 CAG RNA 的细胞中,基因的表达被下调。NUDT16 功能的丧失导致有害核苷酸错误掺入 DNA 中,从而导致 DNA 损伤。我们表明,小 CAG(sCAG)RNA,即从扩增 CAG 转录本中产生的物种,与含有 CUG 的 mRNA 杂交,并形成 CAG-CUG RNA 异源双链体,导致基因沉默,并导致 DNA 损伤和细胞凋亡。这些结果在使用表达扩增 CAG RNA 的小鼠原代神经元和体内 R6/2 HD 转基因小鼠进一步得到了验证。此外,我们鉴定了一种双脒化合物 DB213,它特异性地与 CAG RNA 同源双链体的大沟相互作用,并不利于 CAG-CUG 异源双链体的形成。这种作用随后减轻了体外细胞和体内小鼠疾病模型中 RNA 诱导的沉默复合物(RISC)依赖性沉默。在 DB213 治疗后,HD 小鼠的 DNA 损伤、凋亡和运动缺陷得到了挽救。这项工作确立了 CAG 重复 RNA 导致的 NUDT16 缺陷是 polyQ 疾病的发病机制,并为 HD 和其他 polyQ 疾病提供了潜在的治疗方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/823212359a9c/pnas.2022940118fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/c114ed12e98e/pnas.2022940118fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/cdffee28d6fb/pnas.2022940118fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/dcfe80df2ff7/pnas.2022940118fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/25c78d469db4/pnas.2022940118fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/3970936b88d1/pnas.2022940118fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/b228439a5b62/pnas.2022940118fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/823212359a9c/pnas.2022940118fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/c114ed12e98e/pnas.2022940118fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/cdffee28d6fb/pnas.2022940118fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/dcfe80df2ff7/pnas.2022940118fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/25c78d469db4/pnas.2022940118fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/3970936b88d1/pnas.2022940118fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/b228439a5b62/pnas.2022940118fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73eb/8126783/823212359a9c/pnas.2022940118fig07.jpg

相似文献

1
CAG RNAs induce DNA damage and apoptosis by silencing expression in polyglutamine degeneration.CAG RNAs 通过沉默多聚谷氨酰胺变性中的表达诱导 DNA 损伤和细胞凋亡。
Proc Natl Acad Sci U S A. 2021 May 11;118(19). doi: 10.1073/pnas.2022940118.
2
RNA toxicity induced by expanded CAG repeats in Huntington's disease.亨廷顿舞蹈病中由CAG重复序列扩增引起的RNA毒性。
Brain Pathol. 2016 Nov;26(6):779-786. doi: 10.1111/bpa.12427.
3
Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture.亨廷顿舞蹈症中细胞外囊泡内聚谷氨酰胺和CAG重复RNA的潜在转移:细胞培养中的背景与评估
Cell Mol Neurobiol. 2016 Apr;36(3):459-70. doi: 10.1007/s10571-016-0350-7. Epub 2016 Mar 7.
4
Expression of expanded CAG transcripts triggers nucleolar stress in Huntington's disease.扩张的 CAG 转录本的表达引发亨廷顿病中的核仁应激。
Cerebellum. 2013 Jun;12(3):310-2. doi: 10.1007/s12311-012-0447-6.
5
The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference.重复疾病相关发夹茎区中无间断 CAG 重复的长度决定了通过 RNA 干扰对细胞有毒性的短 CAG 寡核苷酸的数量。
Cell Death Dis. 2022 Dec 30;13(12):1078. doi: 10.1038/s41419-022-05494-1.
6
A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.亨廷顿病的一种致病机制涉及具有神经毒性活性的小 CAG 重复 RNA。
PLoS Genet. 2012;8(2):e1002481. doi: 10.1371/journal.pgen.1002481. Epub 2012 Feb 23.
7
Lack of RAN-mediated toxicity in Huntington's disease knock-in mice.亨廷顿病基因敲入小鼠中缺乏 RAN 介导的毒性。
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4411-4417. doi: 10.1073/pnas.1919197117. Epub 2020 Feb 6.
8
Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.靶向CAG重复RNA可独立于亨廷顿蛋白水平减轻亨廷顿舞蹈病的表型。
J Clin Invest. 2016 Nov 1;126(11):4319-4330. doi: 10.1172/JCI83185. Epub 2016 Oct 10.
9
An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice.JPH3 基因座的反义 CAG 重复转录本介导亨廷顿病样 2 型小鼠中扩增的多聚谷氨酰胺蛋白毒性。
Neuron. 2011 May 12;70(3):427-40. doi: 10.1016/j.neuron.2011.03.021.
10
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.表达突变全长亨廷顿舞蹈病(HD)互补DNA的转基因小鼠:亨廷顿舞蹈病运动变化和选择性神经元丢失的范例
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456.

引用本文的文献

1
Analysis of m7G-related signatures in the tumor immune microenvironment and identification of clinical prognostic regulators in ovarian cancer.卵巢癌肿瘤免疫微环境中m7G相关特征分析及临床预后调节因子鉴定
Front Immunol. 2025 Aug 14;16:1595618. doi: 10.3389/fimmu.2025.1595618. eCollection 2025.
2
Mutant huntingtin induces neuronal apoptosis via derepressing the non-canonical poly(A) polymerase PAPD5.突变型亨廷顿蛋白通过解除对非经典多聚腺苷酸聚合酶PAPD5的抑制来诱导神经元凋亡。
Nat Commun. 2025 Apr 9;16(1):3307. doi: 10.1038/s41467-025-58618-4.
3
Refining Ligand Poses in RNA/Ligand Complexes of Pharmaceutical Relevance: A Perspective by QM/MM Simulations and NMR Measurements.

本文引用的文献

1
Discovery of a potent small molecule inhibiting Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein.通过靶向 CAG 重复 RNA 和聚谷氨酰胺蛋白发现抑制亨廷顿病 (HD) 发病机制的有效小分子。
Sci Rep. 2019 Nov 14;9(1):16872. doi: 10.1038/s41598-019-53410-z.
2
Structural insights into synthetic ligands targeting A-A pairs in disease-related CAG RNA repeats.针对与疾病相关的 CAG RNA 重复序列中 A-A 对的合成配体的结构见解。
Nucleic Acids Res. 2019 Nov 18;47(20):10906-10913. doi: 10.1093/nar/gkz832.
3
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.
通过量子力学/分子力学模拟和核磁共振测量优化具有药物相关性的RNA/配体复合物中的配体构象:一种观点
J Phys Chem Lett. 2025 Feb 20;16(7):1702-1708. doi: 10.1021/acs.jpclett.4c03456. Epub 2025 Feb 10.
4
RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington's disease models.靶向RNA的CRISPR/CasRx系统可缓解亨廷顿舞蹈症模型中的疾病症状。
Mol Neurodegener. 2025 Jan 13;20(1):4. doi: 10.1186/s13024-024-00794-w.
5
A novel aurone RNA CAG binder inhibits the huntingtin RNA-protein interaction.一种新型金合欢素RNA CAG结合剂可抑制亨廷顿蛋白RNA-蛋白质相互作用。
RSC Med Chem. 2024 Jul 17;15(9):3092-3096. doi: 10.1039/d4md00403e. eCollection 2024 Sep 19.
6
Development of a prognostic risk model of uveal melanoma based on N7-methylguanosine-related regulators.基于 N7-甲基鸟苷相关调控因子的葡萄膜黑色素瘤预后风险模型的建立。
Hereditas. 2024 Jul 10;161(1):22. doi: 10.1186/s41065-024-00324-0.
7
Rapid and high-purity differentiation of human medium spiny neurons reveals LMNB1 hypofunction and subtype necessity in modeling Huntington's disease.人类中型多棘神经元的快速高纯度分化揭示了层黏连蛋白β1功能减退以及亨廷顿舞蹈病建模中神经元亚型的必要性。
Inflamm Regen. 2024 Feb 15;44(1):7. doi: 10.1186/s41232-024-00320-x.
8
Multiplatform tear proteomic profiling reveals novel non-invasive biomarkers for diabetic retinopathy.多平台泪液蛋白质组学分析揭示了糖尿病视网膜病变的新型非侵入性生物标志物。
Eye (Lond). 2024 Jun;38(8):1509-1517. doi: 10.1038/s41433-024-02938-0. Epub 2024 Feb 9.
9
Structural investigation of pathogenic RFC1 AAGGG pentanucleotide repeats reveals a role of G-quadruplex in dysregulated gene expression in CANVAS.结构研究致病性 RFC1 AAGGG 五核苷酸重复序列揭示了 G-四链体在 CANVAS 中基因表达失调中的作用。
Nucleic Acids Res. 2024 Mar 21;52(5):2698-2710. doi: 10.1093/nar/gkae032.
10
Antagonistic roles of canonical and Alternative-RPA in disease-associated tandem CAG repeat instability.经典 RPA 和 Alternative-RPA 在与疾病相关的串联 CAG 重复不稳定中的拮抗作用。
Cell. 2023 Oct 26;186(22):4898-4919.e25. doi: 10.1016/j.cell.2023.09.008. Epub 2023 Oct 11.
CAG 重复序列而非多聚谷氨酰胺长度决定亨廷顿病发病时间。
Cell. 2019 Aug 8;178(4):887-900.e14. doi: 10.1016/j.cell.2019.06.036.
4
Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription.突变亨廷顿蛋白损害 PNKP 和 ATXN3,破坏 DNA 修复和转录。
Elife. 2019 Apr 17;8:e42988. doi: 10.7554/eLife.42988.
5
Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.精准切割肌强直性营养不良小鼠模型中的 r(CUG)重复扩展的小分子。
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7799-7804. doi: 10.1073/pnas.1901484116. Epub 2019 Mar 29.
6
Expanded CUG Repeats Trigger Disease Phenotype and Expression Changes through the RNAi Machinery in C. elegans.扩展的 CUG 重复通过 RNAi 机制在秀丽隐杆线虫中触发疾病表型和表达变化。
J Mol Biol. 2019 Apr 19;431(9):1711-1728. doi: 10.1016/j.jmb.2019.03.003. Epub 2019 Mar 14.
7
AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models.AQAMAN,一种双脒基神经元中有毒蛋白包涵体的抑制剂,可改善多聚谷氨酰胺疾病模型的细胞毒性。
J Biol Chem. 2019 Feb 22;294(8):2757-2770. doi: 10.1074/jbc.RA118.006307. Epub 2018 Dec 28.
8
Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration.经鼻内给药实现两种肽类抑制剂脑靶向递送用于转 Polyglutamine 疾病小鼠的联合治疗
Mol Pharm. 2018 Dec 3;15(12):5781-5792. doi: 10.1021/acs.molpharmaceut.8b00938. Epub 2018 Nov 12.
9
Efficient brain uptake and distribution of an expanded CAG RNA inhibitor DB213 via intranasal administration.经鼻腔给予可扩展 CAG RNA 抑制剂 DB213 可实现高效的脑内摄取和分布。
Eur J Pharm Sci. 2019 Jan 15;127:240-251. doi: 10.1016/j.ejps.2018.10.025. Epub 2018 Nov 1.
10
Polyglutamine Repeats in Neurodegenerative Diseases.多聚谷氨酰胺重复在神经退行性疾病中的作用。
Annu Rev Pathol. 2019 Jan 24;14:1-27. doi: 10.1146/annurev-pathmechdis-012418-012857. Epub 2018 Aug 8.